Pcrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pcrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pcrx Today - Breaking & Trending Today

Pacira BioSciences (NASDAQ:PCRX) Hits New 12-Month Low at $25.74

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $25.74 and last traded at $25.76, with a volume of 63285 shares changing hands. The stock had previously closed at $26.25. Analyst Upgrades and Downgrades A number of equities research analysts have commented […] ....

United States , Pacira Biosciences , China Universal Asset Management Co , Jpmorgan Chase Co , Cape Investment Advisory Inc , Pacira Biosciences Inc , Royal Bank , Quadrant Capital Group , Nisa Investment Advisors , Group Wealth Management , Securities Exchange Commission , Needham Company , Get Free Report , Director Gary , Exchange Commission , Wealth Management , Universal Asset Management , Investment Advisors , Capital Group , Cape Investment Advisory , Pacira Biosciences Daily , Nasdaq Pcrx ,

Gotham Asset Management LLC Purchases 3,203 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Gotham Asset Management LLC boosted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 16.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 22,317 shares of the company’s stock after acquiring an additional 3,203 shares during the period. Gotham Asset Management LLC’s holdings in Pacira BioSciences were worth […] ....

United States , Pacira Biosciences , Securities Exchange Commission , Pacira Biosciences Inc , Needham Company , Renaissance Technologies , Frontier Capital Management Co , Gotham Asset Management , Vanguard Group Inc , Holdings Channel , Baillie Gifford Co , Jpmorgan Chase Co , Stephens Investment Management Group , Royal Bank , Free Report , Asset Management , Capital Management , Investment Management Group , Director Gary , Exchange Commission , Visit Holdingschannel , Pacira Biosciences Daily , Nasdaq Pcrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pacira BioSciences, Inc. to Post Q1 2025 Earnings of $0.69 Per Share, Zacks Research Forecasts (NASDAQ:PCRX)

Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Zacks Research dropped their Q1 2025 earnings estimates for Pacira BioSciences in a research report issued to clients and investors on Friday, February 23rd. Zacks Research analyst R. Department now expects that the company will post earnings of $0.69 per share for the quarter, down from their […] ....

United States , Pacira Bioscience , Pacira Biosciences , Piper Sandler , Pacira Biosciences Company Profile , Baillie Gifford Co , Pacira Biosciences Inc , Royal Bank , Needham Company , Hr Department , Frontier Capital Management Co , Renaissance Technologies , Zacks Research , Vanguard Group Inc , Dimensional Fund Advisors , Free Report , Capital Management , Fund Advisors , Get Free Report , Pacira Biosciences Daily , Nasdaq Pcrx , Earnings Estimates ,

Zacks Research Analysts Decrease Earnings Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX)

Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Research analysts at Zacks Research reduced their Q1 2025 EPS estimates for shares of Pacira BioSciences in a research note issued to investors on Friday, February 23rd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.69 for the quarter, […] ....

United States , Pacira Biosciences , Piper Sandler , Pacira Bioscience , Zacks Research , Pacira Biosciences Inc , China Universal Asset Management Co , Royal Bank , Group Wealth Management , Hr Department , Financial Freedom , Torno Capital , Free Report , Wealth Management , Universal Asset Management , Ivy Capital Management , Get Free Report , Pacira Biosciences Daily , Nasdaq Pcrx , Earnings Estimates ,

Q3 2024 EPS Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) Reduced by Analyst

Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities research analysts at Zacks Research decreased their Q3 2024 earnings per share estimates for Pacira BioSciences in a note issued to investors on Wednesday, February 21st. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.59 for the quarter, […] ....

United States , Piper Sandler , Pacira Bioscience , Pacira Biosciences , Hr Department , Needham Company , Torno Capital , Group Wealth Management , Financial Freedom , Zacks Research , Royal Bank , Pacira Biosciences Inc , China Universal Asset Management Co , Free Report , Wealth Management , Universal Asset Management , Ivy Capital Management , Get Free Report , Pacira Biosciences Daily , Nasdaq Pcrx , Earnings Estimates ,